Blocking Lactate Export by Inhibiting the Myc Target MCT1 Disables Glycolysis and Glutathione Synthesis
2013/11/27 by Joanne R. Doherty, Chunying Yang, Kristen E.N. Scott +21 · 30 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Cancer, Hypoxia, and Metabolism #Mitochondrial Function and Pathology #Neuroblastoma Research and Treatments
paper · pdf · doi:10.1158/0008-5472.can-13-2034
Abstract
Myc oncoproteins induce genes driving aerobic glycolysis, including lactate dehydrogenase-A that generates lactate. Here, we report that Myc controls transcription of the lactate transporter SLC16A1/MCT1 and that elevated MCT1 levels are manifest in premalignant and neoplastic Eμ-Myc transgenic B cells and in human malignancies with MYC or MYCN involvement. Notably, disrupting MCT1 function leads to an accumulation of intracellular lactate that rapidly disables tumor cell growth and glycolysis, provoking marked alterations in glycolytic intermediates, reductions in glucose transport, and in levels of ATP, NADPH, and ultimately, glutathione (GSH). Reductions in GSH then lead to increases in hydrogen peroxide, mitochondrial damage, and ultimately, cell death. Finally, forcing glycolysis by metformin treatment augments this response and the efficacy of MCT1 inhibitors, suggesting an attractive combination therapy for MYC/MCT1-expressing malignancies.
Citations
Cited by
- Monocarboxylate Transporters (SLC16): Function, Regulation, and Role in Health and Disease
- The Role of the Microbiome in the Etiopathogenesis of Colon Cancer
- Targeting monocarboxylate transporters (MCTs) in cancer: How close are we to the clinics?
- Lactate metabolism in human health and disease
- Hexokinase detachment from mitochondria drives the Warburg effect to support compartmentalized ATP production
- Protein and nucleotide biosynthesis are coupled by a single rate-limiting enzyme, PRPS2, to drive cancer. [europepmc]
- Cell surface lactate receptor GPR81 is crucial for cancer cell survival. [europepmc]
- Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters. [europepmc]
- Lactate Regulates Metabolic and Pro-inflammatory Circuits in Control of T Cell Migration and Effector Functions. [europepmc]
- MYC, Metabolism, and Cancer. [europepmc]
- Lactate promotes glutamine uptake and metabolism in oxidative cancer cells. [europepmc]
- MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4. [europepmc]
- Glycolytic Metabolism Plays a Functional Role in Regulating Human Pluripotent Stem Cell State. [europepmc]
- The Glia-Neuron Lactate Shuttle and Elevated ROS Promote Lipid Synthesis in Neurons and Lipid Droplet Accumulation in Glia via APOE/D. [europepmc]
- Lactate Metabolism in Human Lung Tumors. [europepmc]
- Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development. [europepmc]
- Short-Chain Fatty Acid Transporters: Role in Colonic Homeostasis. [europepmc]
- Systems analysis of intracellular pH vulnerabilities for cancer therapy. [europepmc]
- Causes, consequences, and therapy of tumors acidosis. [europepmc]
- Metabolic Responses to Reductive Stress. [europepmc]
- Monocarboxylate transporters in cancer. [europepmc]
- Metabolic heterogeneity confers differences in melanoma metastatic potential. [europepmc]
- Solute carrier transporters: the metabolic gatekeepers of immune cells. [europepmc]
- Monocarboxylate Transporters (SLC16): Function, Regulation, and Role in Health and Disease. [europepmc]
- The Warburg Effect 97 Years after Its Discovery. [europepmc]
- Cancer Metabolism: Phenotype, Signaling and Therapeutic Targets. [europepmc]
- Lactate in the Tumor Microenvironment: An Essential Molecule in Cancer Progression and Treatment. [europepmc]
- Lactate metabolism in human health and disease. [europepmc]
- Lactate and lactylation in cancer. [europepmc]
- Energy metabolism in health and diseases. [europepmc]
Related